🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/03/2008 28,60 32,50 28,00 28,30 +0,35% 15,73% 15.890
28/03/2008 33,70 34,70 28,00 28,20 -15,82% 19,88% 36.070
27/03/2008 30,70 33,50 30,70 33,50 +9,12% 9,12% 28.010
26/03/2008 30,20 31,20 29,10 30,70 +0,00% 6,95% 11.700
25/03/2008 30,50 31,00 28,20 30,70 +1,32% 9,18% 24.660
24/03/2008 28,30 30,90 28,30 30,30 +8,99% 9,19% 38.990
20/03/2008 26,80 29,60 25,60 27,80 +13,47% 14,93% 75.840
19/03/2008 25,90 27,20 24,40 24,50 -3,92% 10,81% 20.050
18/03/2008 23,20 25,50 23,20 25,50 +10,39% 9,91% 22.170
17/03/2008 22,80 25,00 21,50 23,10 -0,86% 15,35% 24.640
14/03/2008 26,00 26,40 23,20 23,30 -8,63% 12,31% 20.430
13/03/2008 24,40 25,60 24,30 25,50 +3,66% 5,33% 19.720
12/03/2008 24,90 25,70 23,60 24,60 +4,68% 8,43% 31.130
11/03/2008 19,00 23,50 19,00 23,50 +23,68% 23,68% 21.110
10/03/2008 20,60 20,63 19,00 19,00 -7,77% 7,91% 24.070
07/03/2008 21,20 21,40 20,60 20,60 -3,74% 3,77% 19.450
06/03/2008 21,80 22,70 21,40 21,40 -2,73% 5,96% 12.370
05/03/2008 22,40 23,90 21,60 22,00 -0,90% 10,27% 10.020
04/03/2008 22,80 23,00 21,50 22,20 -3,48% 6,58% 15.750
03/03/2008 24,40 24,40 22,60 23,00 -5,74% 7,38% 13.610
29/02/2008 26,50 26,70 24,40 24,40 -7,58% 8,68% 15.560
28/02/2008 25,90 26,80 25,50 26,40 +3,94% 5,02% 12.850
27/02/2008 24,80 25,80 24,60 25,40 +2,83% 4,84% 13.370
26/02/2008 24,00 25,00 23,80 24,70 +3,78% 5,00% 19.390
25/02/2008 22,70 24,00 22,00 23,80 +8,68% 8,81% 14.380
22/02/2008 22,40 22,90 21,00 21,90 +4,29% 8,48% 20.140
21/02/2008 21,70 23,20 21,00 21,00 -1,41% 10,14% 19.170
20/02/2008 22,30 22,50 20,90 21,30 -2,74% 7,17% 34.920
19/02/2008 23,50 24,10 21,90 21,90 -4,37% 9,36% 30.370
15/02/2008 23,40 24,90 22,60 22,90 -2,55% 9,83% 21.670